Amazonian toxoplasmosis complicated by severe hypoxemic pneumonia and myopericarditis in an immunocompetent adult Authors: Benoit Fréville, Corentin Herrebrecht, Camilla Samawak, Aïssata Dia, Axelle Clerc, Pierre-Laurent Massoure Published: 2026 ABSTRACT BackgroundAmazonian toxoplasmosis (AT) is a severe form of acute toxoplasmosis occurring in the Guiana Shield and characterized by a high frequency of multivisceral involvement, even in immunocompetent individuals. Pulmonary, ocular, hepatic, and lymphatic manifestations are well documented, but cardiac involvement remains exceptionally rare and likely underdiagnosed. The diagnosis is challenging because the early symptoms are nonspecific and cardiac abnormalities may be clinically silent. We present a case of severe AT with documented myopericarditis in a previously healthy young adult (one of the few such cases reported in the literature), highlighting the diagnostic challenges and the importance of early recognition.Case presentationA 25-year-old immunocompetent male soldier deployed in the Amazonian Forest of French Guiana developed high-grade fever, headache with retro-orbital pain, myalgia, rash, and gastrointestinal symptoms (diarrhea). After an initial emergency department visit suggesting dengue fever, his condition deteriorated with respiratory distress, hepatosplenomegaly, hepatic cytolysis, hyponatremia, and radiologic evidence of bilateral pneumonia. Twelve days later, he progressed to septic shock requiring vasopressor support and high-flow oxygen therapy. Extensive infectious workup was negative except for positive serology and polymerase chain reaction for Toxoplasma gondii, supporting a diagnosis of acute toxoplasmosis. These findings were consistent with severe acute toxoplasmosis in the reported clinical context. During follow-up, cardiac troponin value progressively increased. Transthoracic echocardiography revealed a circumferential pericardial effusion, and cardiac magnetic resonance imaging confirmed recent myopericarditis. Colchicine and ramipril were introduced. The patient completed a 6-week course of antiparasitic therapy (trimethoprim–sulfamethoxazole) and was considered cured at the 4-months follow-up after symptom onset.ConclusionsThis case illustrates that AT may lead to severe complications, including myopericarditis, even in previously healthy individuals, a presentation that is very rarely reported in the literature. The diagnosis is challenging due to nonspecific early symptoms, overlap with other tropical infections, and limited access to advanced imaging in remote areas. Clinicians practicing in endemic regions should consider toxoplasmosis in the differential diagnosis of unexplained pneumonia, pericarditis or myocarditis. Background Toxoplasmosis is a parasitic disease caused by Toxoplasma gondii (T. gondii), with a cosmopolitan distribution. It was first discovered in 1908 by Charles Nicolle and Louis Manceaux (Pasteur Institute of Tunis), and the main routes of transmission are the fecal–oral route, through ingestion of sporulated oocysts contaminating vegetables, soil, or water, and the ingestion of bradyzoites (the tissue-encysted stage) from raw or undercooked meat [1]. In immunocompetent adults, infection is usually asymptomatic or mild, most often presenting with nonspecific flu-like symptoms such as lymphadenopathy, fever, fatigue, and myalgia. In contrast, toxoplasmosis poses a significant risk to pregnant women, as primary infection during pregnancy can lead to congenital toxoplasmosis with severe fetal outcomes, and to immunocompromised individuals, such as those with advanced HIV infection (Human Immunodeficiency Virus), in whom reactivation or acute infection may cause life-threatening disease, particularly encephalitis and ocular involvement [2]. However, severe forms have been reported in South America [3]. These “Amazonian toxoplasmosis” (AT) are a severe and emerging form of acute toxoplasmosis caused by the same protozoan parasite, Toxoplasma gondii, but associated with genetically atypical lineages circulating in a sylvatic rainforest cycle. First described in the early 2000s, it has been reported mainly in French Guiana, with similar cases observed in other parts of the Amazon basin. Unlike the cosmopolitan form of toxoplasmosis, which is usually asymptomatic or mild in immunocompetent individuals, AT is frequently severe and may affect individuals regardless of immune status. Transmission is closely linked to environmental exposure in rainforest settings, particularly through contaminated surface water, soil, or consumption of undercooked game meat, in a context of intense circulation of oocysts shed by wild felids and diverse intermediate hosts. The severity of disease is thought to be related to the high genetic diversity and potential virulence of these atypical strains, combined with ecological and climatic factors such as flooding and changes in human–environment interactions [4]. Clinically, AT is characterized by multivisceral involvement, including ocular, pulmonary, hepatic, and cardiac manifestations, and may rapidly progress to life-threatening disease even in immunocompetent individuals [5]. Among these organ involvements, myocarditis has been reported, although it remains rare and difficult to diagnose [6]. Here, we report a rare case of severe AT with myopericarditis involvement in a previously healthy young adult. Case presentation A 25-year-old male French soldier was deployed in the north-western Amazonian Forest of French Guiana as part of an anti-illegal gold mining mission. On day 1 during a mission of several days in jungle, the patient developed high-grade fever (up to 40.6 °C), headaches with retro-orbital pain, myalgia, and polyarthralgia. On day 3, the symptoms worsened with marked asthenia, nausea, and vomiting. He also developed a mild dry cough and a non-pruritic petechial rash involving the trunk, limbs, and face, sparing palms, soles, and scalp. Day 6, he presented to the local emergency department. Clinical examination was unremarkable except for the rash and the laboratory test results in favor of a dengue disease diagnosis: a thrombocytopenia and an elevated CRP (Table 1). He was discharged with symptomatic treatment. Days 11, the patient’s general condition had rapidly deteriorated, with a reported weight loss of 15 kg since his arrival in French Guiana, which was unlikely to be solely attributable to the underlying toxoplasmosis and was more probably related to prolonged physical exertion, including extended walking in equatorial rainforest conditions under a hot and humid climate while carrying heavy loads. Respiratory distress progressively worsened with pulmonary crackles and tachypnea (30 breaths/min), oxygen saturation dropped to 90% on room air, and mild hypotension with systolic blood pressure 90mmHg. Cardiac auscultation was normal. Laboratory investigations revealed no anemia, cytolysis with AST (aspartate aminotransferase) 15xULN (upper limit of normal), ALT (alanine aminotransferase) 10xULN, thrombocytopenia and hyponatremia (Table 1). Microscopic hematuria associated with sterile leukocyturia was found on urinalysis. Renal function remained preserved and lactate dehydrogenase increased (Table 1). From a gastrointestinal standpoint, a non-bloody, non-mucoid diarrhea developed the day before. Tests for malaria, dengue (IgM and NS1), chikungunya, zika, yellow fever, mayaro, Rickettsia conorii, Rickettsia typhi, and leptospirosis (serologies) were all negative. Serologic test for Entamoeba histolytica antibodies and hepatitis (A, B, C) were negative. Urinary antigen tests for Streptococcus pneumoniae and Legionella pneumophila serogroup 1 were negative. Aerobic and anaerobic blood cultures returned sterile. HIV-1 (human immunodeficiency virus) and HIV-2 serology returned negative. A thoraco-abdominal computed tomography (CT) scan revealed bilateral ground-glass opacities, more prominent on the right side, with mild interlobular septal thickening and small bilateral pleural effusions, consistent with pneumonia. The abdominal section showed hepatosplenomegaly, mild ascites, mesenteric infiltration (cf. Fig. 1). Fig. 1Serial chest computed tomography images showing (red arrows) bilateral ground-glass opacities disseminated in the two lungs and the absence of pericardial effusion Serial chest computed tomography images showing (red arrows) bilateral ground-glass opacities disseminated in the two lungs and the absence of pericardial effusion Empiric antibiotic therapy with amoxicillin–clavulanate was initiated. Day 12: the patient, still in the emergency ward, developed a septic shock unresponsive to fluid resuscitation, requiring norepinephrine infusion (Table 1). He also exhibited oxygen desaturation to 88% on ambient air, requiring high-flow oxygen (10 L/min via mask). The infectious disease team recommended switching antibiotics to cefotaxime and spiramycin, and adding doxycycline. AST and ALT further increased to 19×ULN and 13×ULN, respectively (Table 1). The patient was transferred to the intensive care unit (ICU). Day 13: the patient became apyretic overnight. High-flow nasal oxygen (Optiflow™) was increased to 60 L/min with an inspired oxygen fraction (FiO₂) of 60%, and subsequently decreased to 40 L/min as oxygenation improved. Norepinephrine was discontinued without recurrence of hypotension. Day 14: Serological testing, performed on a blood sample collected on day 13 and reported on day 14, returned positive for T. gondii with detectable IgM and negative IgG. This result was subsequently confirmed by polymerase chain reaction (PCR) performed on the same sample, which was sent to mainland France on day 13 and returned positive on day 18, supporting a diagnosis of severe AT. Antimicrobial therapy was adjusted to trimethoprim-sulfamethoxazole (1600/320 mg) twice daily, combined with folinic acid supplementation for 6 weeks. Clinical improvement was noted within 48 h of specific therapy, with resolution of dyspnea and pulmonary crackles, and rapid recovery of digestive symptoms. Fever persisted intermittently (up to 38 °C) but subsided progressively. Oxygen therapy was discontinued on day 18, with SpO₂ 94–95% on room air. The patient was subsequently transferred to the infectious diseases ward, and intravenous sulfamethoxazole/trimethoprim was switched to oral therapy with the same drug regimen on day 19. A few transient febrile peaks recurred without hemodynamic or respiratory deterioration. The patient was then evacuated to mainland France for further follow-up and management on day 22 for continued management. After 48 h, the patient remained clinically stable without dyspnea, although persistent tachycardia and a mild chest pain were reported. Neurological examination and physiotherapy assessment revealed gait instability and cerebellar ataxia, prompting brain magnetic resonance imaging (MRI) to explore possible cerebellitis. Laboratory tests performed on day 25 showed normal complete blood count (CBC) except for a mononucleosis-like syndrome with hyperlymphocytosis. Renal function remained stable, with hyponatremia and elevated liver enzymes. Troponin levels demonstrated a progressive rise between day 23 and day 38 (Table 1). The electrocardiogram (ECG) was unremarkable, with no PR-segment, ST-segment or T wave abnormalities. Transthoracic echocardiography (TTE) on day 26 revealed a non-compressive circumferential pericardial effusion, normal global ventricular function normal left ventricular feeling pressures, but demonstrated a slight impairment of global longitudinal strain, measured at -12%. Cardiac MRI confirmed the normality of cardiac function but demonstrated multiple features consistent with acute myopericarditis, in accordance with the modified Lake Louise criteria [7] (Fig. 2). Repeat TTE on day 33 showed resolution of the pericardial effusion but persistent localized impairment of myocardial strain in the inferior walls. The TTE performed on day 39 showed no further change. Given the cardiac involvement, colchicine 0.5 mg (one tablet twice daily) and ramipril 1.25 mg in the morning were initiated. The ramipril dosage was increased to 2.5 mg 48 h later after confirming good tolerance, in order to optimize left ventricular afterload reduction and provide adequate cardioprotective therapy. Beta-blocker therapy was not initiated because the patient had preserved ventricular function and no clinical signs of heart failure or ventricular arrhythmias. Current European and American guidelines recommend beta-blockers primarily in patients with heart failure with reduced ejection fraction or ventricular arrhythmias [8, 9]. Fig. 2Cardiac Magnetic Resonance (CMR) Steady-State Free Precession sequences in short-axis view (A) and four-chamber view (B): moderate circumferential pericardial effusion (red arrows). CMR T2-mapping short-axis view (C): elevated T2 values (55 ms – normal value 45 ms) in the inferior subepicardial region (blue arrows). CMR TIRM (Turbo Inversion Recovery Magnitude) short-axis view (D): hyperintense signal in the inferior and lateral walls, consistent with recent inflammatory involvement (white arrows). CMR T1 short-axis view 10 min after gadolinium injection (E): subepicardial late gadolinium enhancement in the inferior wall (yellow arrow) Cardiac Magnetic Resonance (CMR) Steady-State Free Precession sequences in short-axis view (A) and four-chamber view (B): moderate circumferential pericardial effusion (red arrows). CMR T2-mapping short-axis view (C): elevated T2 values (55 ms – normal value 45 ms) in the inferior subepicardial region (blue arrows). CMR TIRM (Turbo Inversion Recovery Magnitude) short-axis view (D): hyperintense signal in the inferior and lateral walls, consistent with recent inflammatory involvement (white arrows). CMR T1 short-axis view 10 min after gadolinium injection (E): subepicardial late gadolinium enhancement in the inferior wall (yellow arrow) Neurologically, the patient presented with a cerebellar syndrome responsible for balance and gait disturbances. Brain MRI excluded cerebellitis. Lumbar puncture was proposed following neurologist consultation but was declined by the patient. Symptoms progressively improved with physiotherapy. A second Toxoplasma serology performed 4 weeks later demonstrated seroconversion, with an IgG titre of 691 IU/mL (negative < 3.0 IU/mL; equivocal ≥ 3.0 to < 8.8 IU/mL; positive ≥ 8.8 IU/mL) and an IgM index > 160 UA/mL (negative < 6 UA/mL; equivocal ≥ 6 to < 8 UA/mL; positive ≥ 8 UA/mL). Serologic tests, suggest recent primary infection with substantial and rapid increase in IgG, associated with IgM, in 2 separate samples taken 1 week apart and by absence of an alternative cause. Antimicrobial therapy with sulfamethoxazole/trimethoprim 1600/320 mg twice a day was continued for a total of six weeks. Specialist evaluations concluded the absence of otorhinolaryngologic or ophthalmologic involvement. At discharge, the treatment plan included sulfamethoxazole/trimethoprim, folinic acid, colchicine and ramipril. At the 3-month follow-up consultation (4 months after disease onset), the patient was asymptomatic and considered cured. Ramipril was discontinued, and the troponin level had returned to 0. Discussion Acute toxoplasmosis with life threatening symptoms is more common in South America than in the rest of the world but remains rare in immunocompetent patients [3]. This case report raises two challenging issues: the first concerns the diagnosis of T. gondii infection, and the second relates to the diagnosis of myocarditis, which is particularly well described here. Possible sources of T. gondii contamination include drinking water or consumption of contaminated meat [1]. In jungle operations, standard water disinfection with chlorine tablets is used but is ineffective against T. gondii oocysts, which are highly resistant to chemical inactivation. Effective prevention requires physical filtration or UV irradiation to ensure parasite removal [10]. While water contamination is possible, it remains unlikely as standard chlorination is widely used by troops without frequent outbreaks. Recent data support this, showing only a minority of cases linked to water exposure [11]. In contrast, 50% of cases are associated with wild meat consumption, with ingestion of undercooked peccary remaining the most probable source in this case. Despite the patient reporting consumption of non-bloody meat, reaching internal temperatures of 67–71 °C is the condition to inactivate tissue cysts [12]. T. gondii infection is relatively uncommon among patients with pneumonia, particularly in those without underlying comorbidities [13]. In this case, AT was not initially suspected. During the first days, dengue fever was the primary differential diagnosis, misled by the combination of high fever, headache, retro-orbital pain, a transient skin rash, and biological thrombocytopenia. These features, common in tropical settings, delayed the correct diagnosis. It was only after the development of respiratory distress and the consideration of recent Amazonian forest exposure that other etiologies, such as leptospirosis, were prioritized before confirming toxoplasmosis. In French Guiana, the etiologies of community-acquired pneumonia (CAP) differ significantly from temperate regions. In a series of 275 CAP cases admitted to the Cayenne hospital between 2009 and 2012, Coxiella burnetii was the leading pathogen (38.5%), followed by Mycoplasma pneumoniae (7.6%) and Streptococcus pneumoniae (1.8%). In this cohort, toxoplasmosis was identified in 1.5% of cases (n = 4). Although infrequent, this prevalence remains twice as high as those of Dengue virus (0.7%) and Leptospira sp. (0.7%) in the context of pneumonia [14]. This highlights the rarity of toxoplasmosis as a cause of pneumonia, even in this endemic area. The thoracic CT scan demonstrated findings typical of pulmonary toxoplasmosis. According to the description by de Souza Giassi et al., the most frequent CT features include bilateral smooth septal and peribronchovascular thickening (100%), ground-glass opacities (100%), pleural effusion (66%) as shown in our case report, atelectasis (33%), random nodules (33%) and lymph node enlargement (33%) [15]. Although these thoracic CT findings are common in toxoplasmosis, they can also be observed in other types of pneumonia [5]. When taking a step back and considering the overall clinical picture, several subtle early clues can be identified that point toward T. gondii infection, in addition to the consumption of game meat. Certain biological abnormalities are commonly associated with toxoplasmosis, including anemia (not reported in our case report), hyponatremia and hepatic cytolysis [4]. In a large retrospective, multicenter study conducted across all healthcare facilities in French Guiana between January 2002 and December 2019, the author reported that, among the most severe patients (admitted to ICU), AST levels were elevated to 6.2× ULN and ALT to 4.2× ULN. The mean CRP level was 166 mg/L (compared with 57 mg/L in other hospitalized patients), LDH reached 1107 U/L, and altered renal function was observed in 30% of cases (mean creatinine 288 µmol/L). Hyponatremia was also common, with a mean sodium level of 128 mmol/L in severe cases versus 132 mmol/L in other hospitalized patients. Anemia was present in all hospitalized cases but thrombocytopenia was not reported [11]. In our case, we found similar laboratory abnormalities, except for anemia. Notably, hepatic cytolysis was more pronounced. Among hospitalized patients with toxoplasmosis, the most commonly reported symptoms were fever (93%), gastrointestinal involvement—predominantly diarrhea—(78%), respiratory involvement (74%), and asthenia (66%) [11]. High-grade fever, reaching 40 °C, was observed in our case, consistent with the findings of Demar and al. The febrile course, could extend for up to 15 days without treatment [4, 5]. In endemic regions, differentiating Amazonian toxoplasmosis (AT) from other acute febrile illnesses such as dengue or leptospirosis can be particularly challenging. All three conditions may initially present with fever, rash, myalgia, and systemic symptoms, which often delays the correct diagnosis. However, some clinical features can help orient clinicians. In leptospirosis, moderate forms frequently manifest with aseptic meningitis and the characteristic conjunctival suffusion, which is uncommon in most other tropical febrile illnesses. Severe leptospirosis may progress to jaundice (present in approximately 10% of cases), renal insufficiency, hemorrhagic episodes, and multivisceral failure [16]. In dengue, the clinical presentation is typically dominated by an abrupt onset of high fever, intense myalgia and arthralgia, retro-orbital pain, and a characteristic maculopapular rash. Laboratory findings frequently reveal marked leukopenia and thrombocytopenia, which are key diagnostic clues and are not expected in Amazonian toxoplasmosis. Severe dengue is characterized by increased capillary permeability leading to plasma leakage, mucosal bleeding, and, in the most critical cases, hypovolemic shock [17]. Recognizing these distinctions, although subtle, is crucial for earlier diagnosis and management in endemic settings. Diagnosis of T. gondii infection combines serological, molecular, and microscopic methods. Serological tests detect specific IgM and IgG antibodies to differentiate recent from past infection. PCR assays offer high sensitivity and specificity for identifying T. gondii DNA (deoxyribonucleic acid) in blood or tissue samples, particularly useful when serology is inconclusive. When feasible, microscopic observation of tachyzoites or cysts in tissue confirms the diagnosis. Combining serology with PCR provides the most reliable approach [18]. In this case, the diagnosis of toxoplasmosis was established using serology, confirmed by PCR, both performed on blood samples. In view of the diagnostic findings and the favorable reponse of antibiotic therapy, bronchoscopy with bronchoalveolar lavage was not performed. Complications such as myocarditis and encephalitis in the immunocompetent host are rare, with only a few reports in the medical literature [3]. Although the true number of cases is likely underestimated (since some studies report additional cases) this finding highlights a clear lack of detailed descriptions in the current literature. In a recent study, 57.5% of patients presented with severe forms of toxoplasmosis (i.e., requiring hospitalization) in French Guiana, including 16 documented cases of myocarditis [11]. Moreover, in a global series of toxoplasmosis spanning from 1985 to 2022, 36 cases of cardiac involvement were reported [19]. Cardiac manifestations typically include acute chest pain, fever or systemic symptoms, dyspnea and palpitations [6, 9]. Complications such as arrhythmias, heart failure and cardiac arrest are described [6, 9]. These symptoms may reflect both direct myocardial damage and autoimmune mechanisms triggered by parasite-related antigens, and usually occur after a preceding infectious episode, with cardiac involvement developing within approximately 2–4 weeks [9]. The clinical presentation observed in our patient, involving both myocardial and pericardial inflammation, is consistent with myopericarditis, an entity that should be considered in the differential diagnosis of severe manifestations of Amazonian toxoplasmosis. Although cardiac involvement in Toxoplasma gondii infection is well described in immunocompromised hosts, it remains uncommon and frequently underrecognized in immunocompetent individuals. When present, it may manifest as myocarditis or myopericarditis [20, 21]. The pathophysiology is thought to involve direct invasion of cardiomyocytes by tachyzoites as well as additional myocardial injury mediated by the host inflammatory response to the parasite [20]. Diagnosis primarily relies on serologic testing with IgM and IgG antibodies, with IgM appearing early after exposure and IgG rising within 1–2 weeks and persisting long-term. In situations where myocarditis is suspected and endomyocardial biopsy is not available, serum PCR may improve diagnostic sensitivity, particularly in early infection prior to full seroconversion [20]. In contrast, in immunocompromised patients, toxoplasmosis may evolve toward disseminated and fulminant disease with severe cardiac involvement and a high mortality rate, sometimes diagnosed only at autopsy [22]. From a clinical perspective, toxoplasmic myopericarditis must also be distinguished from other infectious causes of myocardial injury endemic to tropical regions, such as dengue or leptospirosis, which may present with cardiac involvement but typically occur within a broader systemic inflammatory syndrome [23, 24]. Although the prognosis of toxoplasmic myocarditis in immunocompetent patients is generally favorable with appropriate treatment, potentially severe complications—including arrhythmias, acute heart failure, or sudden cardiac death—have been reported, underscoring the importance of early recognition, cardiac monitoring, and prompt initiation of antiparasitic therapy. Treatment typically combines pyrimethamine, sulfadiazine, and folinic acid, with alternatives such as clindamycin or trimethoprim-sulfamethoxazole when necessary. Severe myocarditis may improve with adjunctive corticosteroid therapy, particularly in cases with arrhythmias or conduction disturbances [6]. Some limitations must be acknowledged when interpreting this case. First, cardiac involvement in AT is likely underdiagnosed and references are lacking. The diagnostic process is challenging, as clinical manifestations are often nonspecific and may overlap with systemic symptoms of toxoplasmosis, leading to missed myocarditis in patients presenting with other organ involvement. Second, access to healthcare is limited in remote Amazonian areas, such as the Upper Oyapock region and Camopi [4]; many patients may not seek medical attention, resulting in substantial underreporting of cardiac complications. Third, confirmatory investigations such as cardiac magnetic resonance imaging or endomyocardial biopsy are not systematically available or performed in endemic settings, which may further contribute to diagnostic uncertainty. Finally, strain typing was not performed, which represents a limitation of this report, particularly in the context of potentially virulent Amazonian strains. Conclusion This case illustrates an uncommon and severe presentation of Amazonian acute toxoplasmosis in an immunocompetent adult. Although direct microbiological confirmation of pulmonary or cardiac involvement was not obtained, the combination of positive blood PCR, seroconversion, compatible clinical manifestations, and favorable evolution under anti-toxoplasma therapy strongly supported the diagnosis in this clinical context. Acute toxoplasmosis may present as a severe multisystem disease, including pneumonia, hepatitis, and cardiac involvement, even in immunocompetent individuals. This observation also suggests that myopericarditis may occur later during the recovery phase despite appropriate antimicrobial therapy. In endemic areas, clinicians should therefore consider toxoplasmosis as a potential cause of unexplained pneumonia, pericarditis, or myocarditis, and maintain vigilance for late-onset myopericarditis, during the recovery phase, despite appropriate antimicrobial therapy. Toxoplasma serology should be performed in cases of pneumonia in endemic areas. Table 1The timeline of laboratory test results and clinical dataTest (laboratory reference ranges)Day 6Day 10Day 11Day 13Day 22Day 26Day 37Hemoglobin, g/L (13–18)15,915,313,5/12,414,113,4WBC, ×109/L (4–11)2,44,955,64/8,3811,626,69Neutrophil, ×109/L (1,7–7,7)1,72,843,4/2,642,662,66Eosinophil, ×109/L (0,02–0,63) 0 0,010,01/0,150,170,78Basophil, ×109/L (0–0,11)0,010,010,01/0,10,090,02Lymphocytes, ×109/L (1–4,8)0,61,492,1/4,577,82,61Monocytes, ×109/L (0,18–1)0,10,60,2/0,920,90,62Platelets, ×109/L (150–400) 76 87 110 /328272278Sodium, mmol/l (136–145) 134 131 127 132 133 132 135 Potassium, mmol/l (3,5–5,1)3,74,23,94,54,64,34,3Phosphorus, mmol/l (0,81–1,45)0,65//1,15///Chloride, mmol/l (98–107) 97 95 93 99///PT, % (70–100)76 68 73//95/aPTT P/C (0,8 − 1,2)1,281,151,39//1,15/Albumin, g/L (39,7–49,4)43,4//31,634,7//ALT, U/L (< 41)40 438 542 418 149 169 426 AST, U/L (< 40) 75 608 779 534 70 230 501 Creatinine, µmol/L (65–120)8910989/877774Lactat deshydrogenase, U/L (135–225) 587 / 2061 1927 ///CK, U/L (< 190) 426 / 890 // 2651 6992 CRP, mg/L (< 5)56,968,370,8 96 1,31,32,9Troponin-T, ng/L (< 16,8)///49,459,6 104 283 Procalcitonin, ng/L (< 0,5)//5,39,7///NT-pro BNP, pg/mL (< 125)/// 768 /// Cathecolamines NE, µg.kg·min//0.0167////Abbreviations: WBC, white blood count; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CK, creatine kinase; CRP: c-reactive protein; BNP, b-type natriuretic peptide; NE: norepinephrine; PT: prothrombin time; activated partial thromboplastin time (aPTT), expressed as a patient/control ratio (P/C) Table 1The timeline of laboratory test results and clinical dataTest (laboratory reference ranges)Day 6Day 10Day 11Day 13Day 22Day 26Day 37Hemoglobin, g/L (13–18)15,915,313,5/12,414,113,4WBC, ×109/L (4–11)2,44,955,64/8,3811,626,69Neutrophil, ×109/L (1,7–7,7)1,72,843,4/2,642,662,66Eosinophil, ×109/L (0,02–0,63) 0 0,010,01/0,150,170,78Basophil, ×109/L (0–0,11)0,010,010,01/0,10,090,02Lymphocytes, ×109/L (1–4,8)0,61,492,1/4,577,82,61Monocytes, ×109/L (0,18–1)0,10,60,2/0,920,90,62Platelets, ×109/L (150–400) 76 87 110 /328272278Sodium, mmol/l (136–145) 134 131 127 132 133 132 135 Potassium, mmol/l (3,5–5,1)3,74,23,94,54,64,34,3Phosphorus, mmol/l (0,81–1,45)0,65//1,15///Chloride, mmol/l (98–107) 97 95 93 99///PT, % (70–100)76 68 73//95/aPTT P/C (0,8 − 1,2)1,281,151,39//1,15/Albumin, g/L (39,7–49,4)43,4//31,634,7//ALT, U/L (< 41)40 438 542 418 149 169 426 AST, U/L (< 40) 75 608 779 534 70 230 501 Creatinine, µmol/L (65–120)8910989/877774Lactat deshydrogenase, U/L (135–225) 587 / 2061 1927 ///CK, U/L (< 190) 426 / 890 // 2651 6992 CRP, mg/L (< 5)56,968,370,8 96 1,31,32,9Troponin-T, ng/L (< 16,8)///49,459,6 104 283 Procalcitonin, ng/L (< 0,5)//5,39,7///NT-pro BNP, pg/mL (< 125)/// 768 /// Cathecolamines NE, µg.kg·min//0.0167////Abbreviations: WBC, white blood count; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CK, creatine kinase; CRP: c-reactive protein; BNP, b-type natriuretic peptide; NE: norepinephrine; PT: prothrombin time; activated partial thromboplastin time (aPTT), expressed as a patient/control ratio (P/C) The timeline of laboratory test results and clinical data Abbreviations: WBC, white blood count; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CK, creatine kinase; CRP: c-reactive protein; BNP, b-type natriuretic peptide; NE: norepinephrine; PT: prothrombin time; activated partial thromboplastin time (aPTT), expressed as a patient/control ratio (P/C)